Publication: Molecular pathology of prostate cancer
dc.contributor.coauthor | Roudier, Martine P. | |
dc.contributor.coauthor | Haffner, Michael C. | |
dc.contributor.department | N/A | |
dc.contributor.kuauthor | Kulaç, İbrahim | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.yokid | 170305 | |
dc.date.accessioned | 2024-11-09T23:50:48Z | |
dc.date.issued | 2021 | |
dc.description.abstract | N/A | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 3 | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.volume | 14 | |
dc.identifier.doi | 10.1016/j.path.2021.05.004 | |
dc.identifier.issn | 1875-9181 | |
dc.identifier.link | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109702900&doi=10.1016%2fj.path.2021.05.004&partnerID=40&md5=9d9e6c63e4896aec747f1434eb6bf09b | |
dc.identifier.scopus | 2-s2.0-85109702900 | |
dc.identifier.uri | http://dx.doi.org/10.1016/j.path.2021.05.004 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/14598 | |
dc.keywords | AR | |
dc.keywords | ERG | |
dc.keywords | Intratumoral heterogeneity | |
dc.keywords | Metastasis | |
dc.keywords | Morphology | |
dc.keywords | Prostate cancer | |
dc.keywords | PTEN androgen receptor | |
dc.keywords | Antineoplastic agent | |
dc.keywords | Phosphatidylinositol 3 kinase | |
dc.keywords | Phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase | |
dc.keywords | Transcription factor ERG | |
dc.keywords | Wnt protein | |
dc.keywords | Advanced cancer | |
dc.keywords | AR gene | |
dc.keywords | Cancer cell | |
dc.keywords | Cancer diagnosis | |
dc.keywords | Cancer patient | |
dc.keywords | Cancer prognosis | |
dc.keywords | Cancer resistance | |
dc.keywords | Cell clone | |
dc.keywords | Cell cycle | |
dc.keywords | Clonal variation | |
dc.keywords | DNA repair | |
dc.keywords | Epigenetic modification | |
dc.keywords | Erythroblast | |
dc.keywords | Evidence based medicine | |
dc.keywords | Gene dosage | |
dc.keywords | Gene fusion | |
dc.keywords | Gene loss | |
dc.keywords | Gene rearrangement | |
dc.keywords | Genetic modification | |
dc.keywords | Germline mutation | |
dc.keywords | Histopathology | |
dc.keywords | Human | |
dc.keywords | Metastasis | |
dc.keywords | Molecular diagnosis | |
dc.keywords | Molecular pathology | |
dc.keywords | Morphology | |
dc.keywords | PI3K gene | |
dc.keywords | Precancer | |
dc.keywords | Prediction | |
dc.keywords | Primary tumor | |
dc.keywords | Prostate cancer | |
dc.keywords | PTEN gene | |
dc.keywords | Review | |
dc.keywords | Somatic mutation | |
dc.keywords | Systemic therapy | |
dc.keywords | Transcriptomics | |
dc.keywords | Wnt gene | |
dc.keywords | Genetics | |
dc.keywords | Genomics | |
dc.keywords | Male | |
dc.keywords | Prostate tumor | |
dc.keywords | Genomics | |
dc.keywords | Humans | |
dc.keywords | Pathology, Molecular | |
dc.keywords | Prostatic neoplasms | |
dc.language | English | |
dc.source | Surgical Pathology Clinics | |
dc.subject | Medicine | |
dc.subject | Pathology | |
dc.title | Molecular pathology of prostate cancer | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.authorid | 0000-0003-2003-7567 | |
local.contributor.kuauthor | Kulaç, İbrahim |